OTCMarketsExpert

US Nuclear Corp surges on earnings beat.

Pembelian
OTC:UCLE   US Nuclear Corp.
Huge Earnings beat- detailed below.
LOS ANGELES, CA, Sept. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- US Nuclear Corp. (UCLE)

Sales for the three months ended June 30, 2019 were $1,530,523, an increase of $968,995 or 172% as compared to the same period in 2018
Gross profit was $785,933 compared to $287,799 for the same period in 2018, an increase of 173%
Cash increased from $969,118 to $1,393,915 for the six months ended June 30, 2019
Stock based compensation was $804,131 compared to $328,320 during the same period in 2018
Net loss from operations ($466,019) due to stock-based compensation as the company acquires new partnerships, technology, sales and marketing consultants, and other services to facilitate company growth
US Nuclear Corp., a leading manufacturer and seller of advanced radiation and chemical detection instrumentation, recently announced the financial results for the second quarter ended June 30, 2019.

“We had a very successful and productive second quarter in 2019. Key metrics are increasing, with sales revenue up 172% from the same period last year,” commented Robert I. Goldstein, President, CEO, and Chairman of US Nuclear Corp. “Leaving out the stock-based compensation, our business operation had a dollar profit of $338,112, which is the main reason for the cash increase of $424,797. The increase in sales revenue can be attributed to strong sales growth of our signature products, including: air quality monitors, tritium monitors, and forensic drones. Being first to market with our scientific drones allowed us to establish ourselves at the forefront of this fast-growing industry and we look forward to capitalizing on our momentum.”

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.